Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity

v3.20.1
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Series B Preferred Stock
Total Shareholders’ Equity
Total Shareholders’ Equity
Series B Preferred Stock
Preferred Stock
Series A Preferred
Preferred Stock
Series B Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interests
Beginning balance, shares at Dec. 31, 2018         562 1,875,748 9,511,464     235,032
Beginning balance at Dec. 31, 2018 $ 44,255   $ 42,061   $ 453 $ 41,000 $ 95 $ 233,697 $ (233,184) $ 2,194
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accretion of Series B Preferred Stock discount 170 $ 22   $ 22   $ 22        
Issuance of Common Stock under Share Incentive Plan, shares             181,807      
Issuance of Common Stock under Share Incentive Plan 166   166       $ 2 164    
Dividends and distributions (2,589)   (2,589)           (2,589)  
Net Income (loss) 655   642           642 $ 13
Ending balance, shares at Mar. 31, 2019         562 1,875,748 9,693,271     235,032
Ending balance at Mar. 31, 2019 42,509   40,302   $ 453 $ 41,022 $ 97 233,861 (235,131) $ 2,207
Beginning balance, shares at Dec. 31, 2019         562 1,875,748 9,694,284     234,019
Beginning balance at Dec. 31, 2019 26,007   23,927   $ 453 $ 41,087 $ 97 233,870 (251,580) $ 2,080
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Accretion of Series B Preferred Stock discount 170 $ 22   $ 22   $ 22        
Dividends and distributions (2,589)   (2,589)           (2,589)  
Net Income (loss) (1,877)   (1,868)           (1,868) $ (9)
Ending balance, shares at Mar. 31, 2020         562 1,875,748 9,694,284     234,019
Ending balance at Mar. 31, 2020 $ 21,563   $ 19,492   $ 453 $ 41,109 $ 97 $ 233,870 $ (256,037) $ 2,071